Pfizer agrees to lower price of HIV drug amid knockdown battle with Gilead Sciences
Pfizer Inc. has agreed to allow lower prices on its newest top-selling AIDS medication, moving quickly to expand market access while being on a collision course with the powerful pharmaceutical company. The agreement could…